For instance, two recent studies showed that both the in vivo caspase-1 inhibition and the selective blockade of NLRP3 inflammasome complex significantly attenuated colonic inflammation in spontaneous colitis mice (Zhang et al., 2014; Perera et al., 2018). This evidence concerns the gene CASP1 and colitis.